Poseida Therapeutics Inc (PSTX)
3.19
-0.16
(-4.63%)
USD |
NASDAQ |
May 17, 16:00
3.19
0.00 (0.00%)
After-Hours: 18:54
Poseida Therapeutics Shareholders Equity (Quarterly): 84.59M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 84.59M |
| December 31, 2023 | 103.70M |
| September 30, 2023 | 123.66M |
| June 30, 2023 | 135.30M |
| March 31, 2023 | 157.56M |
| December 31, 2022 | 187.60M |
| September 30, 2022 | 216.31M |
| June 30, 2022 | 65.80M |
| March 31, 2022 | 103.70M |
| Date | Value |
|---|---|
| December 31, 2021 | 156.21M |
| September 30, 2021 | 150.16M |
| June 30, 2021 | 186.58M |
| March 31, 2021 | 227.49M |
| December 31, 2020 | 261.97M |
| September 30, 2020 | 295.84M |
| June 30, 2020 | -205.30M |
| March 31, 2020 | 47.04M |
| December 31, 2019 | -149.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-205.30M
Minimum
Jun 2020
295.84M
Maximum
Sep 2020
119.37M
Average
142.73M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomea Fusion Inc | 135.31M |
| Cartesian Therapeutics Inc | -116.80M |
| Lantern Pharma Inc | 35.77M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 262.58M |
| Total Liabilities (Quarterly) | 177.99M |
| Debt to Equity Ratio | 0.6938 |
| Current Ratio | 2.557 |
| Net Debt Paydown Yield | -0.03% |